Log In
BCIQ
Print this Print this
 

Progensa PCA3 assay

Also known as: PCA3 test

  Manage Alerts
Collapse Summary General Information
Company Hologic Inc.
DescriptionDiagnostic test measuring expression of prostate cancer antigen gene 3 (PCA3)
Molecular Target Not applicable
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsAid in the prediction of a follow-up prostate biopsy result; Aid in the prediction of a prostate cancer biopsy result in men scheduled for an initial prostate biopsy
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

01/06/2016

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today